These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 23570537)
41. Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies. Jossé R; Aninat C; Glaise D; Dumont J; Fessard V; Morel F; Poul JM; Guguen-Guillouzo C; Guillouzo A Drug Metab Dispos; 2008 Jun; 36(6):1111-8. PubMed ID: 18347083 [TBL] [Abstract][Full Text] [Related]
42. Drug metabolizing enzyme and transporter protein profiles of hepatocytes derived from human embryonic and induced pluripotent stem cells. Ulvestad M; Nordell P; Asplund A; Rehnström M; Jacobsson S; Holmgren G; Davidson L; Brolén G; Edsbagge J; Björquist P; Küppers-Munther B; Andersson TB Biochem Pharmacol; 2013 Sep; 86(5):691-702. PubMed ID: 23856292 [TBL] [Abstract][Full Text] [Related]
43. Utility of long-term cultured human hepatocytes as an in vitro model for cytochrome p450 induction. Meneses-Lorente G; Pattison C; Guyomard C; Chesné C; Heavens R; Watt AP; Sohal B Drug Metab Dispos; 2007 Feb; 35(2):215-20. PubMed ID: 17093007 [TBL] [Abstract][Full Text] [Related]
44. Long-term maintenance of functional primary human hepatocytes using small molecules. Katsuda T; Kawamata M; Inoue A; Yamaguchi T; Abe M; Ochiya T FEBS Lett; 2020 Jan; 594(1):114-125. PubMed ID: 31432507 [TBL] [Abstract][Full Text] [Related]
45. Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes. Kimoto E; Walsky R; Zhang H; Bi YA; Whalen KM; Yang YS; Linder C; Xiao Y; Iseki K; Fenner KS; El-Kattan AF; Lai Y Drug Metab Dispos; 2012 Feb; 40(2):407-11. PubMed ID: 22031626 [TBL] [Abstract][Full Text] [Related]
46. Quantitative Expression of Hepatobiliary Transporters and Functional Uptake of Substrates in Hepatic Two-Dimensional Sandwich Cultures: A Comparative Evaluation of Upcyte and Primary Human Hepatocytes. Schaefer M; Morinaga G; Matsui A; Schänzle G; Bischoff D; Süssmuth RD Drug Metab Dispos; 2018 Feb; 46(2):166-177. PubMed ID: 29212823 [TBL] [Abstract][Full Text] [Related]
47. Induction of cytochrome P450 enzymes in primary equine hepatocyte culture. Stefanski A; Mevissen M; Möller AM; Kuehni-Boghenbor K; Schmitz A Toxicol In Vitro; 2013 Oct; 27(7):2023-30. PubMed ID: 23916975 [TBL] [Abstract][Full Text] [Related]
48. In vitro assessment of metabolic drug-drug interaction potential of apixaban through cytochrome P450 phenotyping, inhibition, and induction studies. Wang L; Zhang D; Raghavan N; Yao M; Ma L; Frost CE; Maxwell BD; Chen SY; He K; Goosen TC; Humphreys WG; Grossman SJ Drug Metab Dispos; 2010 Mar; 38(3):448-58. PubMed ID: 19940026 [TBL] [Abstract][Full Text] [Related]
49. Predictive utility of in vitro rifampin induction data generated in fresh and cryopreserved human hepatocytes, Fa2N-4, and HepaRG cells. Templeton IE; Houston JB; Galetin A Drug Metab Dispos; 2011 Oct; 39(10):1921-9. PubMed ID: 21771933 [TBL] [Abstract][Full Text] [Related]
50. Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates. Koyama S; Arakawa H; Itoh M; Masuda N; Yano K; Kojima H; Ogihara T Biopharm Drug Dispos; 2018 Apr; 39(4):187-195. PubMed ID: 29469947 [TBL] [Abstract][Full Text] [Related]
51. Anti-CD28 monoclonal antibody-stimulated cytokines released from blood suppress CYP1A2, CYP2B6, and CYP3A4 in human hepatocytes in vitro. Czerwiński M; Kazmi F; Parkinson A; Buckley DB Drug Metab Dispos; 2015 Jan; 43(1):42-52. PubMed ID: 25326287 [TBL] [Abstract][Full Text] [Related]
52. Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3. Noé J; Portmann R; Brun ME; Funk C Drug Metab Dispos; 2007 Aug; 35(8):1308-14. PubMed ID: 17470528 [TBL] [Abstract][Full Text] [Related]
53. Ellipticine oxidation and DNA adduct formation in human hepatocytes is catalyzed by human cytochromes P450 and enhanced by cytochrome b5. Stiborová M; Poljaková J; Martínková E; Ulrichová J; Simánek V; Dvořák Z; Frei E Toxicology; 2012 Dec; 302(2-3):233-41. PubMed ID: 22917556 [TBL] [Abstract][Full Text] [Related]
54. Cytochrome P450 3A4 mRNA is a more reliable marker than CYP3A4 activity for detecting pregnane X receptor-activated induction of drug-metabolizing enzymes. Fahmi OA; Kish M; Boldt S; Obach RS Drug Metab Dispos; 2010 Sep; 38(9):1605-11. PubMed ID: 20566695 [TBL] [Abstract][Full Text] [Related]
55. Opposite regulation of hepatic breast cancer resistance protein in type 1 and 2 diabetes mellitus. He L; Yang Y; Guo C; Yao D; Liu HH; Sheng JJ; Zhou WP; Ren J; Liu XD; Pan GY Eur J Pharmacol; 2014 Feb; 724():185-92. PubMed ID: 24342797 [TBL] [Abstract][Full Text] [Related]
56. Evaluation of 23 lots of commercially available cryopreserved hepatocytes for induction assays of human cytochromes P450. Yajima K; Uno Y; Murayama N; Uehara S; Shimizu M; Nakamura C; Iwasaki K; Utoh M; Yamazaki H Drug Metab Dispos; 2014 May; 42(5):867-71. PubMed ID: 24553381 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of the endothelin receptor antagonists ambrisentan, darusentan, bosentan, and sitaxsentan as substrates and inhibitors of hepatobiliary transporters in sandwich-cultured human hepatocytes. Hartman JC; Brouwer K; Mandagere A; Melvin L; Gorczynski R Can J Physiol Pharmacol; 2010 Jun; 88(6):682-91. PubMed ID: 20628435 [TBL] [Abstract][Full Text] [Related]
58. Muscone Induces CYP1A2 and CYP3A4 Enzyme Expression in L02 Human Liver Cells and CYP1A2 and CYP3A11 Enzyme Expression in Kunming Mice. Liu S; Cheng Y; Rao M; Tang M; Dong Z Pharmacology; 2017; 99(5-6):205-215. PubMed ID: 28110334 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of luciferin-isopropyl acetal as a CYP3A4 substrate for human hepatocytes: effects of organic solvents, cytochrome P450 (P450) inhibitors, and P450 inducers. Li AP Drug Metab Dispos; 2009 Aug; 37(8):1598-603. PubMed ID: 19451401 [TBL] [Abstract][Full Text] [Related]
60. Effect of SLCO1B1 polymorphism on induction of CYP3A4 by rifampicin. Niemi M; Kivistö KT; Diczfalusy U; Bodin K; Bertilsson L; Fromm MF; Eichelbaum M Pharmacogenet Genomics; 2006 Aug; 16(8):565-8. PubMed ID: 16847425 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]